Antiretroviral treatment found to reduce risk of developing active TB


Researchers have discovered that antiretroviral treatment (ART) lowered the risk of developing active tuberculosis (TB) in HIV co-infected people by reducing the activation of the body’s immune response. The study, published in Frontiers in Immunology Journal, was a collaboration between scientists from the Wellcome Centre for Infectious Diseases Research in Africa at the University of Cape Town (UCT) and the Francis Crick Institute in the United Kingdom. The findings indicate that  ART is an effective way to reduce the risk of TB in HIV co-infected people, reducing TB incidence between 54% and 92% at the individual level.

Other news